Finance

Lists
DMAAU:NASDAQ
Drugs Made In America Acquisition Units
10,99 $
+1,85%
(+0,20) 1D
21 սեպ, 09:34:32 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DMAAU...
Mkt. cap
264,38 մլն
Avg. vol.
3,00
Volume
0,00
52-wk high
12,50 $
52-wk low
10,30 $
Shares outstanding
23,03 մլն
Mkt. cap
264,38 մլն
Avg. vol.
3,00
Volume
0,00
52-wk high
12,50 $
52-wk low
10,30 $
Shares outstanding
23,03 մլն
News stories
From web sources and news partners
About Drugs Made In America Acquisition Units
CEO-
Employees-
Founded2024
Headquarters-
Sector-
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
263,70 հզր
2,09 մլն
143,30 հզր
136,93 հզր
Operating expense
263,70 հզր
2,09 մլն
143,30 հզր
136,93 հզր
Total operating expenses
263,70 հզր
2,09 մլն
143,30 հզր
136,93 հզր
Operating income
-263,70 հզր
-2,09 մլն
-143,30 հզր
-136,93 հզր
Other non operating income
-
-
-
-
EBT including unusual items
2,18 մլն
212,96 հզր
1,97 մլն
1,73 մլն
EBT excluding unusual items
2,18 մլն
212,96 հզր
1,97 մլն
1,73 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
2,18 մլն
212,96 հզր
1,97 մլն
1,73 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2,45 մլն
2,30 մլն
2,11 մլն
1,86 մլն
Interest expense
-
-
-
-
Net interest expenses
2,45 մլն
2,30 մլն
2,11 մլն
1,86 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps